In this episode, obesity medicine specialist and OMA clinical education director Dr. Nicholas Pennings interviews Dr. Robert Kushner, highlighted speaker from the Overcoming Obesity 2021 Conference, about The Semaglutide Treatment Effect in People with Obesity (STEP) Trials. Topics covered include the results of the four STEP trails, obstacles to treating obesity, new obesity treatments in the pipeline, and the opportunities for increasing obesity education for future clinicians.
You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.
Episode Guest
Nicholas Pennings, DO, FOMA, Dipl. ABOM
Resources Mentioned
In episode three of our four-part Advocacy series, Dr. Nicholas Pennings, an Obesity Medicine Specialist and Clinical Education Director at OMA, engages in a...
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts...
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association...